Update: 27.07.2022
Last week: 28 week 2022 (11.07.2022 - 17.07.2022)
Last full month: June 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 101 454 | -1.7% | 6.3% | 0 | 19 819 326 | -1.3% | 5.7% | 0 | -2.4% |
| MoM | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| YTD | 6 298 488 | 29.5% | 6.0% | 0.8 | 1 244 774 238 | 53.8% | 5.7% | 1.1 | 13.1% |
| MAT | 14 704 466 | 49.7% | 6.7% | 1.7 | 2 726 283 212 | 76.7% | 6.2% | 1.9 | 11.0% |
| DEXALGIN | |||||||||
| WoW | 26 213 | 2.5% | 0.7% | 0 | 11 128 218 | 2.8% | 1.8% | 0 | 0.9% |
| MoM | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| YTD | 1 119 303 | 28.7% | 0.8% | 0.1 | 463 573 779 | 40.6% | 2.1% | 0.3 | 8.9% |
| MAT | 2 088 801 | 9.4% | 0.8% | 0 | 834 693 042 | 17.7% | 2.1% | 0.1 | 4.3% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 71 839 | 1.8% | 56.5% | -0.4 | 36 271 781 | 1.5% | 61.5% | -0.9 | 2.4% |
| MoM | 336 051 | -12.5% | 56.7% | -0.6 | 172 180 989 | -12.1% | 62.6% | 0.5 | -11.5% |
| YTD | 2 877 778 | 7.5% | 58.6% | -8.1 | 1 451 193 669 | 21.5% | 64.0% | -6 | 22.3% |
| MAT | 5 482 962 | 9.8% | 61.5% | -4.6 | 2 681 107 754 | 25.1% | 66.9% | -3.1 | 18.0% |
| ESPUMISAN BABY | |||||||||
| WoW | 22 159 | 0.8% | 37.9% | 0 | 14 011 735 | 1.1% | 50.6% | -0.1 | 0.8% |
| MoM | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| YTD | 857 688 | -4.3% | 39.0% | -2.9 | 527 965 144 | 2.2% | 52.5% | -4.5 | 2.9% |
| MAT | 1 624 396 | -7.4% | 39.8% | -1.3 | 982 754 303 | 1.7% | 53.7% | -1.2 | -4.4% |
| FASTUM | |||||||||
| WoW | 15 542 | -1.5% | 1.1% | 0 | 8 166 996 | -1.4% | 2.3% | -0.1 | -2.1% |
| MoM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| YTD | 661 380 | -12.5% | 1.2% | -0.2 | 335 286 599 | -3.5% | 2.7% | -0.4 | 3.1% |
| MAT | 1 290 626 | -13.0% | 1.3% | -0.2 | 627 916 622 | -5.0% | 2.8% | -0.3 | 0.2% |
| IODOMARIN | |||||||||
| WoW | 47 441 | 0.2% | 21.0% | 0.2 | 9 548 154 | 0.3% | 9.5% | -0.1 | -0.7% |
| MoM | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| YTD | 1 647 207 | 9.0% | 18.5% | -0.1 | 332 982 922 | 17.3% | 8.4% | 0 | 9.5% |
| MAT | 3 303 333 | 20.2% | 20.5% | 2.1 | 641 583 770 | 21.9% | 9.3% | 0.7 | 7.6% |
| LIOTON | |||||||||
| WoW | 22 901 | -0.7% | 2.4% | 0 | 23 658 580 | -1.0% | 4.6% | -0.1 | -0.9% |
| MoM | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| YTD | 821 694 | -12.7% | 2.5% | -0.3 | 831 539 301 | 10.3% | 4.9% | -0.4 | -3.8% |
| MAT | 1 572 439 | -10.5% | 2.6% | -0.1 | 1 480 714 432 | 8.6% | 5.3% | -0.3 | -5.5% |
| MEZYM | |||||||||
| WoW | 286 121 | 2.5% | 27.9% | 0.5 | 44 469 369 | 4.0% | 20.2% | 0.2 | 0.7% |
| MoM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| YTD | 11 897 791 | 26.1% | 29.5% | 3.7 | 1 820 675 300 | 36.4% | 21.2% | 1.8 | 10.1% |
| MAT | 23 221 871 | 26.9% | 30.9% | 4.2 | 3 395 030 030 | 32.9% | 22.5% | 2.1 | 9.5% |
| MIG 400 | |||||||||
| WoW | 132 085 | -1.2% | 3.6% | -0.1 | 15 501 226 | -1.0% | 2.5% | -0.1 | 0.9% |
| MoM | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| YTD | 5 009 610 | 7.8% | 3.5% | 0 | 587 377 227 | 10.5% | 2.7% | -0.2 | 8.9% |
| MAT | 10 251 483 | 14.5% | 3.7% | 0.3 | 1 172 676 042 | 16.9% | 2.9% | 0.1 | 4.3% |
| PROSTAMOL | |||||||||
| WoW | 20 587 | -1.6% | 17.5% | -0.4 | 28 173 527 | -2.6% | 18.1% | -1.1 | 0.7% |
| MoM | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| YTD | 1 000 874 | -10.3% | 20.7% | -3.7 | 1 405 808 772 | 1.0% | 22.2% | -4.8 | 5.9% |
| MAT | 2 024 976 | -4.4% | 22.6% | -2 | 2 714 254 182 | 4.1% | 24.1% | -2.9 | 3.9% |
| RESPERO MYRTOL | |||||||||
| WoW | 9 527 | 3.2% | 8.1% | 0.6 | 4 461 210 | 2.0% | 7.9% | 0.6 | -4.7% |
| MoM | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
| YTD | 732 195 | 202.1% | 9.1% | 5.8 | 341 018 479 | 191.9% | 8.8% | 5 | 10.5% |
| MAT | 1 236 667 | 113.6% | 8.0% | 3.8 | 569 065 053 | 101.7% | 7.9% | 3 | 11.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 6 298 488 | 29.5% | 6.0% | 0.8 | 1 244 774 238 | 53.8% | 5.7% | 1.1 | 13.1% |
| DEXALGIN | 1 119 303 | 28.7% | 0.8% | 0.1 | 463 573 779 | 40.6% | 2.1% | 0.3 | 8.9% |
| ESPUMISAN (ADULTS) | 2 877 778 | 7.5% | 58.6% | -8.1 | 1 451 193 669 | 21.5% | 64.0% | -6 | 22.3% |
| ESPUMISAN BABY | 857 688 | -4.3% | 39.0% | -2.9 | 527 965 144 | 2.2% | 52.5% | -4.5 | 2.9% |
| FASTUM | 661 380 | -12.5% | 1.2% | -0.2 | 335 286 599 | -3.5% | 2.7% | -0.4 | 3.1% |
| IODOMARIN | 1 647 207 | 9.0% | 18.5% | -0.1 | 332 982 922 | 17.3% | 8.4% | 0 | 9.5% |
| LIOTON | 821 694 | -12.7% | 2.5% | -0.3 | 831 539 301 | 10.3% | 4.9% | -0.4 | -3.8% |
| MEZYM | 11 897 791 | 26.1% | 29.5% | 3.7 | 1 820 675 300 | 36.4% | 21.2% | 1.8 | 10.1% |
| MIG 400 | 5 009 610 | 7.8% | 3.5% | 0 | 587 377 227 | 10.5% | 2.7% | -0.2 | 8.9% |
| PROSTAMOL | 1 000 874 | -10.3% | 20.7% | -3.7 | 1 405 808 772 | 1.0% | 22.2% | -4.8 | 5.9% |
| RESPERO MYRTOL | 732 195 | 202.1% | 9.1% | 5.8 | 341 018 479 | 191.9% | 8.8% | 5 | 10.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 14 704 466 | 49.7% | 6.7% | 1.7 | 2 726 283 212 | 76.7% | 6.2% | 1.9 | 11.0% |
| DEXALGIN | 2 088 801 | 9.4% | 0.8% | 0 | 834 693 042 | 17.7% | 2.1% | 0.1 | 4.3% |
| ESPUMISAN (ADULTS) | 5 482 962 | 9.8% | 61.5% | -4.6 | 2 681 107 754 | 25.1% | 66.9% | -3.1 | 18.0% |
| ESPUMISAN BABY | 1 624 396 | -7.4% | 39.8% | -1.3 | 982 754 303 | 1.7% | 53.7% | -1.2 | -4.4% |
| FASTUM | 1 290 626 | -13.0% | 1.3% | -0.2 | 627 916 622 | -5.0% | 2.8% | -0.3 | 0.2% |
| IODOMARIN | 3 303 333 | 20.2% | 20.5% | 2.1 | 641 583 770 | 21.9% | 9.3% | 0.7 | 7.6% |
| LIOTON | 1 572 439 | -10.5% | 2.6% | -0.1 | 1 480 714 432 | 8.6% | 5.3% | -0.3 | -5.5% |
| MEZYM | 23 221 871 | 26.9% | 30.9% | 4.2 | 3 395 030 030 | 32.9% | 22.5% | 2.1 | 9.5% |
| MIG 400 | 10 251 483 | 14.5% | 3.7% | 0.3 | 1 172 676 042 | 16.9% | 2.9% | 0.1 | 4.3% |
| PROSTAMOL | 2 024 976 | -4.4% | 22.6% | -2 | 2 714 254 182 | 4.1% | 24.1% | -2.9 | 3.9% |
| RESPERO MYRTOL | 1 236 667 | 113.6% | 8.0% | 3.8 | 569 065 053 | 101.7% | 7.9% | 3 | 11.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 101 454 | -1.7% | 6.3% | 0 | 19 819 326 | -1.3% | 5.7% | 0 | -2.4% |
| DEXALGIN | 26 213 | 2.5% | 0.7% | 0 | 11 128 218 | 2.8% | 1.8% | 0 | 0.9% |
| ESPUMISAN (ADULTS) | 71 839 | 1.8% | 56.5% | -0.4 | 36 271 781 | 1.5% | 61.5% | -0.9 | 2.4% |
| ESPUMISAN BABY | 22 159 | 0.8% | 37.9% | 0 | 14 011 735 | 1.1% | 50.6% | -0.1 | 0.8% |
| FASTUM | 15 542 | -1.5% | 1.1% | 0 | 8 166 996 | -1.4% | 2.3% | -0.1 | -2.1% |
| IODOMARIN | 47 441 | 0.2% | 21.0% | 0.2 | 9 548 154 | 0.3% | 9.5% | -0.1 | -0.7% |
| LIOTON | 22 901 | -0.7% | 2.4% | 0 | 23 658 580 | -1.0% | 4.6% | -0.1 | -0.9% |
| MEZYM | 286 121 | 2.5% | 27.9% | 0.5 | 44 469 369 | 4.0% | 20.2% | 0.2 | 0.7% |
| MIG 400 | 132 085 | -1.2% | 3.6% | -0.1 | 15 501 226 | -1.0% | 2.5% | -0.1 | 0.9% |
| PROSTAMOL | 20 587 | -1.6% | 17.5% | -0.4 | 28 173 527 | -2.6% | 18.1% | -1.1 | 0.7% |
| RESPERO MYRTOL | 9 527 | 3.2% | 8.1% | 0.6 | 4 461 210 | 2.0% | 7.9% | 0.6 | -4.7% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 497 446 | -24.3% | 5.3% | -0.3 | 98 872 806 | -25.6% | 4.9% | -0.4 | -19.5% |
| DEXALGIN | 125 262 | -19.0% | 0.7% | -0.1 | 53 648 115 | -17.5% | 1.9% | -0.2 | -7.7% |
| ESPUMISAN (ADULTS) | 336 051 | -12.5% | 56.7% | -0.6 | 172 180 989 | -12.1% | 62.6% | 0.5 | -11.5% |
| ESPUMISAN BABY | 107 613 | -10.3% | 39.2% | 0.9 | 67 424 622 | -10.2% | 51.8% | 1.3 | -12.4% |
| FASTUM | 81 084 | -10.5% | 1.0% | 0 | 42 286 626 | -8.5% | 2.4% | 0 | -6.8% |
| IODOMARIN | 236 425 | 11.0% | 20.7% | 3.8 | 49 256 818 | 6.2% | 9.8% | 1.3 | -9.2% |
| LIOTON | 112 553 | 0.8% | 2.4% | 0.1 | 118 711 335 | 1.7% | 4.7% | 0.3 | -5.0% |
| MEZYM | 1 269 037 | -19.2% | 26.4% | -1.4 | 193 037 160 | -20.4% | 18.4% | -1.8 | -15.0% |
| MIG 400 | 643 782 | -7.6% | 3.8% | 0 | 76 185 236 | -7.8% | 2.7% | 0 | -7.7% |
| PROSTAMOL | 103 714 | -11.6% | 18.3% | -0.1 | 144 326 267 | -12.8% | 19.6% | -0.1 | -11.1% |
| RESPERO MYRTOL | 56 986 | -19.6% | 7.5% | 0.5 | 27 009 657 | -20.4% | 7.3% | 0.4 | -24.5% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs